Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Most of my bids have shown properly on the LII. It's "wiggly". But I'm able to get some fills here around the .825.
The way they're trading this puppy you'd think something was getting ready to pop.
Short squeeze potential imo.
SCYX 1.79. Bottom basing. Trick is having the patience to see if it holds.
SCYX daily
Nice list you put together. Good work! I was just looking over the charts and thinking there's been some quiet accumulation. Thinking this wont be staying in its sideways channel much longer. Once the holidays clear out this may see some decent growth. Fundamentally, as you put, there's a lot going on.
Might have to go for another swing here. That's what I'm thinking. Though... a low of .75 is a new low.
No risk, no reward right?
Offering price is over$2. Gangsters holding this down.
Let'r rip!!!
°00000000000000000000001
Yeah. Someone tell me how to rake that in.
500k Heights Capital. Beautiful baby.
Level II is showing a little action. This puppy WANTS the $$!!!
Such a low float. Shorty aint gonna hold this down long imo.
ENSC .842 looking to set up a squeeze. Who knows how much she'll move. Probably not much yet. Shorts are having too much fun with it.
Just started buying again. .84. https://finance.yahoo.com/news/diamond-equity-research-initiates-coverage-130000643.html
This is what post rever.se split looks like
If I would have realized how to play the RS volatility back in ... well, way back...
Anyway, thanks for being here Monk. I follow your posts quite often.
Cheers.
Now is the time to keep an eye on your longs for tax selloff discounts!! Having the cash to take advantage is the place to be. Oh, and just so you know, I'm just a reed in the wind and am not certified in even the micros that make shit. Just a retired navy vet.
JMO.
My latest are SCYX and ENSC. GREEN is all that matters.
I wish I had more time to spend here. All YOU GUYS are awesome!!!
Just sayin. Close the up gap.
NRBO, another RS bio play. I missed this one. ENSC looks to be recovering a bit now.
LOOKS like an easy 50%+ up gap to fill. Even with a little dilution.
1.30. Reasonable. Eom
No doubt!! Probably triggered A LOT of stop losses.
I started playing post RS volatility a while ago. CERTAINLY has its risk/reward factor.
Cheers.
ENSC pre market dip. I took a few bites under 1.10. & 1.12.
Doesn't take much to wiggle a low floater.
Discount. S-1 notice of effect posted. Looks like they'll dilute right into another RS.
Gotta love the volatility of these bios after the RS's though.
CFRX .147 check out the weekly. Took the dip under the $2 SCYX. 1.90. See how that works out for the swing.
Didn't even check their filings. Thanks! That's quite the dilution for sure.
Watching the chart thinking it may be back in its channel and worth a quick swing.
SOBR
Added a "follow" mark.
SOBR looks to be nearing the $ again. Why?? Who knows!
SCYNEXIS Announces FDA Approval of Second Indication for BREXAFEMME® (ibrexafungerp tablets) for Reduction in Incidence of Recurrent Vulvovaginal Candidiasis
https://finance.yahoo.com/news/scynexis-announces-fda-approval-second-130000442.html
Thinking this puppy plays well into next summer.
Now I wait for the chart. Or I should say, "my chart" set up. But I made my plan. Small bite 1st.
This could still see under the $ but I took a nibble here. 1.03.
They get news follow up with Janssen and this could see quite the momentum.
Dear Stockholder:
We are pleased to invite you to attend the Special Meeting of stockholders (the “Special Meeting”) of Hepion Pharmaceuticals, Inc. (“Hepion” or the “Company”), which will be held on December 15, 2022 at 9:00 a.m. local time at our offices, located at 399 Thornall Street, First Floor, Edison, NJ 08837, for the following purposes:
1. To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-two (1-for-2) to a maximum of a one-for-twenty (1-for-20) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders; and
2. To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.
Our board of directors has fixed the close of business on November 8, 2022 as the record date for a determination of stockholders entitled to notice of, and to vote at, the Special Meeting or any adjournment or postponement thereof.
https://ih.advfn.com/stock-market/NASDAQ/hepion-pharmaceuticals-HEPA/stock-news/89607816/proxy-statement-definitive-def-14a
How is this going to work for US shareholders holding ALRTF shares thru Nevada?
The Ordinary Shares have been approved for quotation on the OTCQB tier of the OTC Markets Group under the trading symbol “ALRTF”.
In consequence of the Redomicile Merger, ALR Nevada expects to file a Form 15 with the SEC to terminate the registration of the Common Stock under the Exchange Act and to suspend its reporting obligations with respect to the Common Stock under the Exchange Act.
SCYNEXIS, Inc.Novel Anti-Infective Treatments
https://www.scynexis.com/pipeline
https://www.scynexis.com/?_sc_token=v2%253ArCFB5M7kDhF0DendplAumDfp0mLJQmmPjXibbF655Pwpp8L8St9zJ5JWXuLRyKtUtDU3NLAry760CeTu07jPC2-7zJNvjIcdmALhP5-txfDhpy-ro8W8Uv93cVU_P05u-1Nm3Y4zfahqmFmswTq5LuZmc2e1aC9Ss1Nnefn-7ep8OcQJeNtAIyo0DvbfqJpL
https://finviz.com/quote.ashx?t=SCYX&p=d
Price history...
https://www.dividendinvestor.com/dividend-news/?symbol=scyx
Looking better than I thought. See how this puppy plays into 1st half 2023.
Lol. Out 2.19. Paid for dinner.
Pushing on up!
TOVX (aka SYN) .712 Still on my list for playing the technical side.
TOVX pincher
So am I wrong that this is now a one hit wonder that has about 6 months to live? Maybe LifeSci sees the writing on the wall. I never cared much for them myself. My take has been they provide funding and short their own companies like any other hedge fund betting on the typical bio to fail.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053691/000143774922027266/dffn20220930_10q.htm
https://finviz.com/quote.ashx?t=DFFN&p=d
Their next study initiates 1st Q 2023, IF they can make it happen.
Do your DD. I haven't looked at this one since before their RS.
MYNZ $9.50 PM 9.50/10.08
$9.50$0.58(6.50%)
Bid9.50Ask10.08
Vol2.5KLight
Just saw this is having a proxy battle. See what shakes out.
https://finance.yahoo.com/news/lifesci-special-opportunities-responds-recent-222000344.html
https://finance.yahoo.com/news/diffusion-pharmaceuticals-sees-significant-progress-113000901.html